SCEL (sciellin) is a precursor protein of the cornified envelope that plays crucial roles in epithelial differentiation and barrier function. The protein is characterized by a central core of nonidentical repeats, with each repeat encoded by a single exon in a unique genomic organization 1. SCEL functions in keratinocyte differentiation and is expressed in stratified epithelia displaying barrier properties, with expression correlating with terminal differentiation markers during embryonic development 1. The protein contains a LIM domain that may facilitate protein associations and localize SCEL to the cornified envelope. In cancer contexts, SCEL demonstrates complex tumor suppressor and oncogenic activities depending on cancer type. In colorectal cancer, SCEL mediates mesenchymal-to-epithelial transition by activating the β-catenin-E-cadherin axis and WNT signaling, with higher expression in primary tumors than hepatic metastases 2. Similarly, in oral squamous cell carcinoma, SCEL acts as a tumor suppressor by inhibiting the TGF-β/Smad pathway 3. Conversely, in pancreatic and thyroid cancers, SCEL promotes tumor progression through Notch and JAK2/STAT3 signaling pathways, respectively 45. SCEL also shows diagnostic potential, with elevated expression in papillary thyroid carcinoma providing significant diagnostic value 6.